IMARC Group, a leading market research company, has recently released a report titled “Angioplasty Balloons Market Report by Product Type (Normal Balloons, Cutting Balloons, Drug Eluting Balloons, Scoring Balloons), Application (Coronary Angioplasty, Peripheral Angioplasty), Material (Nylon, Polyurethane, Silicone Urethane Co-Polymers, and Others), End-User (Hospitals, Ambulatory Surgery Centers, and Others), and Region 2025-2033”. The study provides a detailed analysis of the industry, including the global angioplasty balloons market share, trends, size, and industry trends forecast. The report also includes competitor and regional analysis and highlights the latest advancements in the market.
The global angioplasty balloons market size reached USD 2.52 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.20 Billion by 2033, exhibiting a growth rate (CAGR) of 2.7% during 2025-2033.
The angioplasty balloons market will grow significantly. Key trends are shaping its future. By 2025, the demand for angioplasty balloons will rise due to more people having cardiovascular diseases. Technological advancements will also play a big role. New balloon designs, like drug-eluting balloons, will improve treatment and safety. In emerging markets, healthcare spending is increasing. This means more people will have access to angioplasty procedures. As healthcare systems focus on heart health, the market for angioplasty balloons will thrive. Expect innovation, rising demand, and better patient outcomes.
Market Dynamics of the Angioplasty Balloons Market
Rising Prevalence of Cardiovascular Diseases
The angioplasty balloons market is growing rapidly. This growth is due to the rise in cardiovascular diseases (CVDs) worldwide. CVDs, like coronary artery disease and heart attacks, are major health issues. They lead to high rates of illness and death. Sedentary lifestyles, poor diets, and obesity are significant factors in this trend.
As the population ages, more people will develop CVDs, increasing the demand for angioplasty procedures. Angioplasty balloons are essential in these procedures. They widen narrowed or blocked blood vessels, restoring normal blood flow. Healthcare providers prefer minimally invasive techniques like balloon angioplasty. These methods are effective and offer shorter recovery times than traditional surgery. Therefore, the growing burden of CVDs drives up the demand for angioplasty balloons, fueling market growth.
Technological Advancements in Balloon Designs
Technology is greatly impacting the angioplasty balloons market. New designs and materials are improving performance and safety. A key innovation is the drug-eluting balloon (DEB). This device releases medication into the arterial wall during the procedure, reducing the risk of restenosis, or re-narrowing of the blood vessel. High-pressure and ultra-compliant balloons are also significant developments. They allow for more effective lesion dilation while minimizing trauma to the vessel. Manufacturers are enhancing delivery systems for these balloons, making them easier for healthcare professionals to use. These advancements lead to better patient outcomes and higher success rates for procedures.
As a result, angioplasty is becoming the preferred method for treating vascular conditions. With ongoing technological evolution, the market for angioplasty balloons is set to grow. Demand for safer and more effective treatment options will drive this expansion.
Increasing Healthcare Expenditure and Access to Treatment
Healthcare spending is rising, especially in emerging markets. This boost is driving growth in the angioplasty balloon market. With more investment from governments and private sectors, healthcare infrastructure is improving. Advanced medical technologies and treatments are becoming more accessible. Regions that once had limited cardiovascular care now see more angioplasty procedures. Preventive healthcare and early interventions are also on the rise.
More patients are seeking treatment for heart conditions. Health insurance and reimbursement policies play a crucial role here. When financial barriers are reduced, patients are more likely to opt for angioplasty. As healthcare systems evolve, the demand for angioplasty balloons will continue to grow. This reflects the broader trend of increasing access to cardiovascular treatments.
Angioplasty Balloons Market Report Segmentation:
By Product Type:
· Normal Balloons
· Cutting Balloons
· Drug Eluting Balloons
· Scoring Balloons
Normal balloons represented the largest segment by product type due to their widespread use in routine angioplasty procedures and cost-effectiveness.
By Application:
· Coronary Angioplasty
· Peripheral Angioplasty
Coronary angioplasty represented the largest segment by application because of the high prevalence of coronary artery diseases globally.
By Material:
· Nylon
· Polyurethane
· Silicone Urethane Co-Polymers
· Others
By the material, the market is segmented into nylon, polyurethane, silicone urethane co-polymers, and others.
By End User:
· Hospitals
· Ambulatory Surgery Centers
· Others
Ambulatory surgery centers represented the largest segment by end user due to the increasing preference for outpatient procedures that offer quicker recovery times.
Regional Insights:
· North America
· Asia-Pacific
· Europe
· Latin America
· Middle East and Africa
North America was the largest market by region, driven by the high incidence of cardiovascular diseases and advanced healthcare infrastructure.
Competitive Landscape with Key Players:
The competitive landscape of the angioplasty balloons market size has been studied in the report with the detailed profiles of the key players operating in the market.
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
My name is Nitin Sharma, and I am a research analyst at IMARC Group, specializing in market trends and data analysis to provide insights and support strategic decision-making.
Write a comment ...